LYLin Yan

Lin Yan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lin Yan has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Erdi Zhang

    Department of Laboratory Medicine/Clinical Research Center of Laboratory Medicine, West China Hospital, Sichuan University, 37 Guo Xue Xiang, Chengdu, Sichuan Province 610041, China

    2 shared publications
  • Yi Li

    Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China

    2 shared publications
  • Yuwen Ma

    Department of Laboratory Medicine West China Hospital Sichuan University Chengdu Sichuan China

    2 shared publications
  • Bei Cai

    Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China

    1 shared publication
  • Bin Wei

    Department of Laboratory Medicine/Clinical Research Center of Laboratory Medicine, West China Hospital, Sichuan University, 37 Guo Xue Xiang, Chengdu, Sichuan Province 610041, China

    1 shared publication
  • Binwu Ying

    Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China

    1 shared publication

Latest Publications

  • Open Access

    Single‐Cell Profiling Reveals Clonally Expanded CX3CR1 + T Cells in Anti‐NMDA Receptor Encephalitis

    by Lin Yan, Erdi Zhang, Yuwen Ma, Zirui Meng, Sisi Li, Yimeng Ren, Xiaohe Tian, Yangyi He, Giuseppe Battaglia, Dong Zhou, et al.

    Anti‐ N‐methyl‐D‐aspartate receptor encephalitis (NMDAR‐E) is a prevalent autoimmune neurological disorder, yet T cell‐driven immunopathology and its contributions to therapeutic resistance and fulminant neuroinflammation remain poorly defined. Integrative single‐cell multi‐omic profiling, combining single‐cell RNA sequencing, single‐cell T cell receptor (TCR) sequencing, and cellular indexing of transcriptomes and epitopes by sequencing, is applied to systematically map peripheral and cerebrospinal fluid (CSF) immune landscapes in treatment‐naïve NMDAR‐E patients, with orthogonal validation conducted across independent cohorts via multiparameter flow cytometry and ex vivo NR1 peptide stimulation. Clonally expanded CX3CR1‐expressing CD4 + and CD8 + T cells are identified as a core disease‐associated effector population, characterized by high predicted affinity for the pathogenic GluN1 N368/G369 epitope, robust proinflammatory and cytotoxic transcriptional programs, and enhanced intercellular crosstalk with activated B cells through major histocompatibility complex (MHC), CD99, and macrophage migration inhibitory factor signaling axes. Preferentially enriched in patient CSF, these cells produce elevated interferon‐γ (IFN‐γ) and tumor necrosis factor‐α (TNF‐α) upon antigen‐specific stimulation, collectively highlighting a disease‐associated inflammatory T cell state linked to peripheral immune activation and CNS immune remodeling, with potential translational relevance for future biomarker and therapeutic investigation.


  • Open Access

    Development and preliminary clinical verification of an immune age model based on peripheral immune cells

    by Bin Wei, Xinhua Dai, Erdi Zhang, Chuan Li, Jiansen Mao, Weihua Feng, Lu Yang, Lin Yan, Jie Chen, Yi Li

  • Open Access

    Monitoring mitochondrial function in peripheral T cells to assess immune status and graft health after kidney transplantation

    by Erdi Zhang, Zhengli Wan, Yuwen Ma, Yamei Li, Qixiang Zhou, Bei Cai, Yi Li, Feng Li, Binwu Ying, Lin Yan

    Introduction: Kidney transplantation is the preferred treatment for end-stage renal disease, but immune-mediated graft dysfunction remains a major barrier to long-term success. Conventional indicators such as serum creatinine and proteinuria are not immune-specific, and kidney biopsy is unsuitable for routine use. Mitochondrial function, a critical regulator of immune activation, may provide novel biomarkers for immune monitoring in transplantation. Methods: In this study, the percentage of peripheral immune cells with low mitochondrial membrane potential (MMP-Low%) and mitochondrial mass (MM) were assessed in 30 kidney transplant recipients and 44 healthy controls. Of the 30 transplant recipients, 15 provided paired samples before transplantation and at one month after transplantation with preserved graft function, while the other 15 had impaired graft function. Flow cytometry was used to measure lymphocyte subsets and mitochondrial parameters, which were further evaluated across specific T cell populations. Results: The results showed that increased age correlated with lower MMP-Low% and higher MM. Patients with impaired graft function showed significantly reduced MMP-Low% and elevated MM, suggesting enhanced metabolic activation, while those with preserved graft function displayed increased MMP-Low% and decreased MM, reflecting a quiescent metabolic profile consistent with immunosuppression. Discussion: These findings indicate that peripheral T cell mitochondrial metrics may serve as sensitive, dynamic, and non-invasive biomarkers for post-transplant immune monitoring.


  • Open Access

    2bRAD-M reveals circulating microbiome in chronic antibody-mediated rejection (CAMR) and IgA nephropathy (IgAN) after kidney transplantation

    by Yan-Xin Tao, Er-Di Zhang, Jia-Xi Yue, Zheng-Li Wan, Ji-Wen Fan, Yi Li, Yu Fan, Lin Yan

    Kidney transplantation is currently the most effective method for treating end-stage renal disease. However, postoperative-related rejection and IgA nephropathy remains a serious obstacle to the long-term survival of kidney transplant patients. Its pathogenesis is not fully understood, and potential causative factors remain to be explored. In this study, we used 2bRAD-M to analyze differences in the peripheral blood microbiome of renal transplant recipients who were stable postoperatively (STABLE) and those who developed chronic antibody-mediated rejection (CAMR) or IgA nephropathy (IgAN) recurrence. Thirty one renal transplant patients were recruited, including 12 STABLE, 8 CAMR and 11 IgAN patients after kidney transplantation. 2bRAD-M was used to characterize the microbiota in peripheral blood to explore the presence of microbial differences. Differences in microbial community composition were observed between CAMR, IgAN and STABLE. The alpha diversity of CAMR and IgAN was all higher than STABLE, there are also differences in beta diversity. LEfSe was performed to identify different abundance taxa, 21 discriminative features between CAMR and STABLE, 39 discriminative features between IgAN and STABLE. The mean decrease Gini index and random forest analysis indicated that Staphylococcus_epidermidis might serve as indicator bacteria for CAMR, Kocuria_palustris might serve as indicator bacteria for IgAN. ROC analysis was performed to assess the performance of some optimal marker models, and the average AUC value achieved 89.6% between CAMR and STABLE, 67.4% between IgAN and STABLE. Functional annotation analysis showed 4353 different COGs and 378 related signaling pathways between CAMR and STABLE, 4396 different COGs and 384 related signaling pathways between CAMR and STABLE. The first 2bRAD-M microbiome study of CAMR and IgAN after renal transplantation showed a potential association between the circulating microbiome and the disease, and provided a possible target and basis for subsequent studies of the mechanisms underlying the development and progression of CAMR and IgAN after renal transplantation.

  • Open Access

    T淋巴细胞线粒体功能与抗NMDAR脑炎疾病进程的相关性研究

    by 玉雯 马, 尔狄 张, 霖 曹, 祉茵 王, 旻晋 王, 峰 李, 斌武 应, 琳 严

    探讨抗NMDAR脑炎(anti-N-methyl-D-aspartate receptor encephalitis, NMDAR-E)患者T淋巴细胞线粒体功能变化特征及其与免疫耗竭状态的相关性。 本研究纳入2025年1–3月在四川大学华西医院神经内科确诊的抗NMDAR脑炎患者25例(轻症14例,重症11例)及健康对照16名,采用流式细胞术检测患者外周血与脑脊液中免疫细胞分布,评估低线粒体膜电位细胞比例(low mitochondrial membrane potential, MMP-Low%)、线粒体质量(mitochondrial mass, MM)及PD-1表达水平。 重症患者脑脊液中CD3+和CD4+ T细胞占比、CD3+、CD4+和CD8+ T细胞的MMP-Low%以及CD3和CD8+ T细胞的MM均高于配对外周血(均P+和CD8+初始T细胞和中央记忆T细胞亚群MMP-Low%下降(P+初始T细胞和中央记忆T细胞亚群的PD-1阳性细胞比例上升(P+ T细胞MMP-Low%和外周血淋巴细胞占比可作为区分抗NMDAR-E脑炎患者病情轻重的潜在免疫代谢标志物。